Request for Free Sample

Table of Contents:

1. Introduction

1.1 Market Definition

1.2 Scope (Inclusion and Exclusions)

1.3 Research Assumptions

2. Executive Summary

2.1 Market Overview

2.2 Regional Synopsis

2.3 Competitive Summary

3. Research Methodology

3.1 Top-Down Approach

3.2 Bottom-up Approach

3.3. Data Validation

3.4 Primary Interviews

4. Market Dynamics Impact Analysis

4.1 Market Driving Factors Analysis

4.1.2 Drivers

4.1.2 Restraints

4.1.3 Opportunities

4.1.4 Challenges

4.2 PESTLE Analysis

    1. Porter’s Five Forces Model

5. Statistical Insights and Trends Reporting

5.1 Incidence and Prevalence of Chronic and Acute Pain Conditions (2023)

5.2 Prescription Trends for Non-opioid Pain Patches (2023), by Region

5.3 Healthcare Spending on Pain Management Therapies, by Region (Government, Commercial, Private, Out-of-Pocket), 2023

6. Competitive Landscape

6.1 List of Major Companies, By Region

6.2 Market Share Analysis, By Region

6.3 Product Benchmarking

6.3.1 Product specifications and features

6.3.2 Pricing

6.4 Strategic Initiatives

6.4.1 Marketing and promotional activities

6.4.2 Distribution and Supply Chain Strategies

6.4.3 Expansion plans and new product launches

6.4.4 Strategic partnerships and collaborations

6.5 Technological Advancements

6.6 Market Positioning and Branding

7. Non-opioid Pain Patches Market Segmentation, by Patch Type

7.1 Chapter Overview

7.2 Lidocaine Patches

7.2.1 Lidocaine Patches Market Trends Analysis (2020-2032)

7.2.2 Lidocaine Patches Market Size Estimates and Forecasts to 2032 (USD Million)

7.3 Diclofenac Patches

7.3.1 Diclofenac Patches Market Trends Analysis (2020-2032)

7.3.2 Diclofenac Patches Market Size Estimates and Forecasts to 2032 (USD Million)

7.4 Methyl Salicylate Patches

7.4.1 Methyl Salicylate Patches Market Trends Analysis (2020-2032)

7.4.2 Methyl Salicylate Patches Market Size Estimates and Forecasts to 2032 (USD Million)

7.5 Capsaicin Patches

7.5.1 Capsaicin Patches Market Trends Analysis (2020-2032)

7.5.2 Capsaicin Patches Market Size Estimates and Forecasts to 2032 (USD Million)

7.6 Ketoprofen Patches

7.6.1 Ketoprofen Patches Market Trends Analysis (2020-2032)

7.6.2 Ketoprofen Patches Market Size Estimates and Forecasts to 2032 (USD Million)

7.7 Others (Herbal, Menthol, etc.)

7.7.1 Others (Herbal, Menthol, etc.) Market Trends Analysis (2020-2032)

7.7.2 Others (Herbal, Menthol, etc.) Market Size Estimates and Forecasts to 2032 (USD Million)

8. Non-opioid Pain Patches Market Segmentation, by Distribution Channel

8.1 Chapter Overview

8.2 Retail Pharmacies

8.2.1 Retail Pharmacies Market Trends Analysis (2020-2032)

8.2.2 Retail Pharmacies Market Size Estimates and Forecasts to 2032 (USD Million)

8.3 Hospital Pharmacies

8.3.1 Hospital Pharmacies Market Trends Analysis (2020-2032)

8.3.2 Hospital Pharmacies Market Size Estimates and Forecasts to 2032 (USD Million)

8.4 Online Pharmacies

8.4.1 Online Pharmacies Market Trends Analysis (2020-2032)

8.4.2 Online Pharmacies Market Size Estimates and Forecasts to 2032 (USD Million)

8.5 Others (Supermarkets/Hypermarkets, DTC)

8.5.1 Others (Supermarkets/Hypermarkets, DTC) Market Trends Analysis (2020-2032)

8.5.2 Others (Supermarkets/Hypermarkets, DTC) Market Size Estimates and Forecasts to 2032 (USD Million)

9. Regional Analysis

9.1 Chapter Overview

9.2 North America

9.2.1 Trends Analysis

9.2.2 North America Non-opioid Pain Patches Market Estimates and Forecasts, by Country (2020-2032) (USD Million)

9.2.3 North America Non-opioid Pain Patches Market Estimates and Forecasts, by Patch Type (2020-2032) (USD Million)  

9.2.4 North America Non-opioid Pain Patches Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Million)

9.2.5 USA

9.2.5.1 USA Non-opioid Pain Patches Market Estimates and Forecasts, by Patch Type (2020-2032) (USD Million)

9.2.5.2 USA Non-opioid Pain Patches Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Million)

9.2.6 Canada

9.2.6.1 Canada Non-opioid Pain Patches Market Estimates and Forecasts, by Patch Type (2020-2032) (USD Million)

9.2.6.2 Canada Non-opioid Pain Patches Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Million)

9.2.7 Mexico

9.2.7.1 Mexico Non-opioid Pain Patches Market Estimates and Forecasts, by Patch Type (2020-2032) (USD Million)

9.2.7.2 Mexico Non-opioid Pain Patches Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Million)

9.3 Europe

9.3.1 Eastern Europe

9.3.1.1 Trends Analysis

9.3.1.2 Eastern Europe Non-opioid Pain Patches Market Estimates and Forecasts, by Country (2020-2032) (USD Million)

9.3.1.3 Eastern Europe Non-opioid Pain Patches Market Estimates and Forecasts, by Patch Type (2020-2032) (USD Million)  

9.3.1.4 Eastern Europe Non-opioid Pain Patches Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Million)

9.3.1.5 Poland

9.3.1.5.1 Poland Non-opioid Pain Patches Market Estimates and Forecasts, by Patch Type (2020-2032) (USD Million)

9.3.1.5.2 Poland Non-opioid Pain Patches Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Million)

9.3.1.6 Romania

9.3.1.6.1 Romania Non-opioid Pain Patches Market Estimates and Forecasts, by Patch Type (2020-2032) (USD Million)

9.3.1.6.2 Romania Non-opioid Pain Patches Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Million)

9.3.1.7 Hungary

9.3.1.7.1 Hungary Non-opioid Pain Patches Market Estimates and Forecasts, by Patch Type (2020-2032) (USD Million)

9.3.1.7.2 Hungary Non-opioid Pain Patches Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Million)

9.3.1.8 Turkey

9.3.1.8.1 Turkey Non-opioid Pain Patches Market Estimates and Forecasts, by Patch Type (2020-2032) (USD Million)

9.3.1.8.2 Turkey Non-opioid Pain Patches Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Million)

9.3.1.9 Rest of Eastern Europe

9.3.1.9.1 Rest of Eastern Europe Non-opioid Pain Patches Market Estimates and Forecasts, by Patch Type (2020-2032) (USD Million)

9.3.1.9.2 Rest of Eastern Europe Non-opioid Pain Patches Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Million)

9.3.2 Western Europe

9.3.2.1 Trends Analysis

9.3.2.2 Western Europe Non-opioid Pain Patches Market Estimates and Forecasts, by Country (2020-2032) (USD Million)

9.3.2.3 Western Europe Non-opioid Pain Patches Market Estimates and Forecasts, by Patch Type (2020-2032) (USD Million)  

9.3.2.4 Western Europe Non-opioid Pain Patches Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Million)

9.3.2.5 Germany

9.3.2.5.1 Germany Non-opioid Pain Patches Market Estimates and Forecasts, by Patch Type (2020-2032) (USD Million)

9.3.2.5.2 Germany Non-opioid Pain Patches Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Million)

9.3.2.6 France

9.3.2.6.1 France Non-opioid Pain Patches Market Estimates and Forecasts, by Patch Type (2020-2032) (USD Million)

9.3.2.6.2 France Non-opioid Pain Patches Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Million)

9.3.2.7 UK

9.3.2.7.1 UK Non-opioid Pain Patches Market Estimates and Forecasts, by Patch Type (2020-2032) (USD Million)

9.3.2.7.2 UK Non-opioid Pain Patches Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Million)

9.3.2.8 Italy

9.3.2.8.1 Italy Non-opioid Pain Patches Market Estimates and Forecasts, by Patch Type (2020-2032) (USD Million)

9.3.2.8.2 Italy Non-opioid Pain Patches Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Million)

9.3.2.9 Spain

9.3.2.9.1 Spain Non-opioid Pain Patches Market Estimates and Forecasts, by Patch Type (2020-2032) (USD Million)

9.3.2.9.2 Spain Non-opioid Pain Patches Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Million)

9.3.2.10 Netherlands

9.3.2.10.1 Netherlands Non-opioid Pain Patches Market Estimates and Forecasts, by Patch Type (2020-2032) (USD Million)

9.3.2.10.2 Netherlands Non-opioid Pain Patches Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Million)

9.3.2.11 Switzerland

9.3.2.11.1 Switzerland Non-opioid Pain Patches Market Estimates and Forecasts, by Patch Type (2020-2032) (USD Million)

9.3.2.11.2 Switzerland Non-opioid Pain Patches Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Million)

9.3.2.12 Austria

9.3.2.12.1 Austria Healthcare Predictive Analytic Market Estimates and Forecasts, by Patch Type (2020-2032) (USD Million)

9.3.2.12.2 Austria Non-opioid Pain Patches Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Million)

9.3.2.13 Rest of Western Europe

9.3.2.13.1 Rest of Western Europe Non-opioid Pain Patches Market Estimates and Forecasts, by Patch Type (2020-2032) (USD Million)

9.3.2.13.2 Rest of Western Europe Non-opioid Pain Patches Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Million)

9.4 Asia Pacific

9.4.1 Trends Analysis

9.4.2 Asia Pacific Non-opioid Pain Patches Market Estimates and Forecasts, by Country (2020-2032) (USD Million)

9.4.3 Asia Pacific Non-opioid Pain Patches Market Estimates and Forecasts, by Patch Type (2020-2032) (USD Million)  

9.4.4 Asia Pacific Non-opioid Pain Patches Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Million)

9.4.5 China

9.4.5.1 China Non-opioid Pain Patches Market Estimates and Forecasts, by Patch Type (2020-2032) (USD Million)

9.4.5.2 China Non-opioid Pain Patches Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Million)

9.4.6 India

9.4.5.1 India Non-opioid Pain Patches Market Estimates and Forecasts, by Patch Type (2020-2032) (USD Million)

9.4.5.2 India Non-opioid Pain Patches Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Million)

9.4.5 Japan

9.4.5.1 Japan Non-opioid Pain Patches Market Estimates and Forecasts, by Patch Type (2020-2032) (USD Million)

9.4.5.2 Japan Non-opioid Pain Patches Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Million)

9.4.6 South Korea

9.4.6.1 South Korea Non-opioid Pain Patches Market Estimates and Forecasts, by Patch Type (2020-2032) (USD Million)

9.4.6.2 South Korea Non-opioid Pain Patches Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Million)

9.4.7 Vietnam

9.4.7.1 Vietnam Non-opioid Pain Patches Market Estimates and Forecasts, by Patch Type (2020-2032) (USD Million)

9.2.7.2 Vietnam Healthcare Predictive Analytic Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Million)

9.4.8 Singapore

9.4.8.1 Singapore Non-opioid Pain Patches Market Estimates and Forecasts, by Patch Type (2020-2032) (USD Million)

9.4.8.2 Singapore Non-opioid Pain Patches Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Million)

9.4.9 Australia

9.4.9.1 Australia Non-opioid Pain Patches Market Estimates and Forecasts, by Patch Type (2020-2032) (USD Million)

9.4.9.2 Australia Non-opioid Pain Patches Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Million)

9.4.10 Rest of Asia Pacific

9.4.10.1 Rest of Asia Pacific Non-opioid Pain Patches Market Estimates and Forecasts, by Patch Type (2020-2032) (USD Million)

9.4.10.2 Rest of Asia Pacific Non-opioid Pain Patches Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Million)

9.5 Middle East and Africa

9.5.1 Middle East

9.5.1.1 Trends Analysis

9.5.1.2 Middle East Non-opioid Pain Patches Market Estimates and Forecasts, by Country (2020-2032) (USD Million)

9.5.1.3 Middle East Non-opioid Pain Patches Market Estimates and Forecasts, by Patch Type (2020-2032) (USD Million)  

9.5.1.4 Middle East Non-opioid Pain Patches Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Million)

9.5.1.5 UAE

9.5.1.5.1 UAE Non-opioid Pain Patches Market Estimates and Forecasts, by Patch Type (2020-2032) (USD Million)

9.5.1.5.2 UAE Non-opioid Pain Patches Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Million)

9.5.1.6 Egypt

9.5.1.6.1 Egypt Non-opioid Pain Patches Market Estimates and Forecasts, by Patch Type (2020-2032) (USD Million)

9.5.1.6.2 Egypt Non-opioid Pain Patches Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Million)

9.5.1.7 Saudi Arabia

9.5.1.7.1 Saudi Arabia Non-opioid Pain Patches Market Estimates and Forecasts, by Patch Type (2020-2032) (USD Million)

9.5.1.7.2 Saudi Arabia Non-opioid Pain Patches Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Million)

9.5.1.8 Qatar

9.5.1.8.1 Qatar Non-opioid Pain Patches Market Estimates and Forecasts, by Patch Type (2020-2032) (USD Million)

9.5.1.8.2 Qatar Non-opioid Pain Patches Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Million)

9.5.1.9 Rest of Middle East

9.5.1.9.1 Rest of Middle East Non-opioid Pain Patches Market Estimates and Forecasts, by Patch Type (2020-2032) (USD Million)

9.5.1.9.2 Rest of Middle East Non-opioid Pain Patches Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Million)

9.5.2 Africa

9.5.2.1 Trends Analysis

9.5.2.2 Africa Non-opioid Pain Patches Market Estimates and Forecasts, by Country (2020-2032) (USD Million)

9.5.2.3 Africa Non-opioid Pain Patches Market Estimates and Forecasts, by Patch Type (2020-2032) (USD Million)  

9.5.2.4 Africa Non-opioid Pain Patches Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Million)

9.5.2.5 South Africa

9.5.2.5.1 South Africa Non-opioid Pain Patches Market Estimates and Forecasts, by Patch Type (2020-2032) (USD Million)

9.5.2.5.2 South Africa Non-opioid Pain Patches Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Million)

9.5.2.6 Nigeria

9.5.2.6.1 Nigeria Non-opioid Pain Patches Market Estimates and Forecasts, by Patch Type (2020-2032) (USD Million)

9.5.2.6.2 Nigeria Non-opioid Pain Patches Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Million)

9.5.2.7 Rest of Africa

9.5.2.7.1 Rest of Africa Non-opioid Pain Patches Market Estimates and Forecasts, by Patch Type (2020-2032) (USD Million)

9.5.2.7.2 Rest of Africa Non-opioid Pain Patches Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Million)

9.6 Latin America

9.6.1 Trends Analysis

9.6.2 Latin America Non-opioid Pain Patches Market Estimates and Forecasts, by Country (2020-2032) (USD Million)

9.6.3 Latin America Non-opioid Pain Patches Market Estimates and Forecasts, by Patch Type (2020-2032) (USD Million)  

9.6.4 Latin America Non-opioid Pain Patches Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Million)

9.6.5 Brazil

9.6.5.1 Brazil Non-opioid Pain Patches Market Estimates and Forecasts, by Patch Type (2020-2032) (USD Million)

9.6.5.2 Brazil Non-opioid Pain Patches Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Million)

9.6.6 Argentina

9.6.6.1 Argentina Non-opioid Pain Patches Market Estimates and Forecasts, by Patch Type (2020-2032) (USD Million)

9.6.6.2 Argentina Non-opioid Pain Patches Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Million)

9.6.7 Colombia

9.6.7.1 Colombia Non-opioid Pain Patches Market Estimates and Forecasts, by Patch Type (2020-2032) (USD Million)

9.6.7.2 Colombia Non-opioid Pain Patches Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Million)

9.6.8 Rest of Latin America

9.6.8.1 Rest of Latin America Non-opioid Pain Patches Market Estimates and Forecasts, by Patch Type (2020-2032) (USD Million)

9.6.8.2 Rest of Latin America Non-opioid Pain Patches Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Million)

10. Company Profiles

10.1 Novartis AG 

10.1.1 Company Overview

10.1.2 Financial

10.1.3 Products/ Services Offered

110.1.4 SWOT Analysis

10.2 Allergan plc 

10.2.1 Company Overview

10.2.2 Financial

10.2.3 Products/ Services Offered

10.2.4 SWOT Analysis

10.3 Pfizer Inc. 

             10.3.1 Company Overview

10.3.2 Financial

10.3.3 Products/ Services Offered

10.3.4 SWOT Analysis

10.4 Acorda Therapeutics, Inc. 

10.4.1 Company Overview

10.4.2 Financial

10.4.3 Products/ Services Offered

10.4.4 SWOT Analysis

10.5 Sorrento Therapeutics, Inc. 

             10.5.1 Company Overview

10.5.2 Financial

10.5.3 Products/ Services Offered

10.5.4 SWOT Analysis

10.6 Teva Pharmaceutical Industries Ltd. 

             10.6.1 Company Overview

10.6.2 Financial

10.6.3 Products/ Services Offered

10.6.4 SWOT Analysis

10.7 Endo Pharmaceuticals Inc. 

             10.7.1 Company Overview

10.7.2 Financial

10.7.3 Products/ Services Offered

10.7.4 SWOT Analysis

10.8 Mylan N.V. 

10.8.1 Company Overview

10.8.2 Financial

10.8.3 Products/ Services Offered

10.8.4 SWOT Analysis

10.9 Teikoku Seiyaku Co., Ltd. 

10.9.1 Company Overview

10.9.2 Financial

10.9.3 Products/ Services Offered

10.9.4 SWOT Analysis

10.10 Hisamitsu Pharmaceutical Co., Inc. 

             10.9.1 Company Overview

10.9.2 Financial

10.9.3 Products/ Services Offered

10.9.4 SWOT Analysis

11. Use Cases and Best Practices

12. Conclusion